Adalvo Limited
PolandAll drugs from this manufacturer
-
The medicine is used in adults with acute myeloid leukemia to maintain control over the disease (maintenance of remission).
Dosage form: tablets, film-coated
Active substance Dosage azacitidine 300 mg ATC: L01BC07
-
This medicine is used in adults with acute myeloid leukemia to maintain control over the disease (maintenance of remission). It works by preventing the growth of cancer cells.
Dosage form: tablets, film-coated
Active substance Dosage azacitidine 200 mg ATC: L01BC07
-
The medicine is used to treat relapsing-remitting multiple sclerosis (MS) in patients aged 13 years and older. It helps prevent the immune system from damaging the brain and spinal cord and may slow the progression of the disease.
Dosage form: capsules, hard, intestinal
Active substance Dosage dimethyl fumarate 120 mg ATC: L04AX07
-
Balfumon is used to treat relapsing-remitting multiple sclerosis (MS) in patients aged 13 years and older. It helps prevent the immune system from damaging the brain and spinal cord and may slow the progression of the disease.
Dosage form: capsules, hard, intestinal
Active substance Dosage dimethyl fumarate 240 mg ATC: L04AX07
-
The medicine is used to treat relapsing-remitting multiple sclerosis (MS) in patients aged 13 years and older. It helps prevent the immune system from damaging the brain and spinal cord, which may slow the progression of the disease.
Dosage form: capsules, hard, intestinal
Active substance Dosage dimethyl fumarate 120 mg ATC: L04AX07
-
The medicine is used to treat relapsing-remitting multiple sclerosis (MS) in patients aged 13 years and older. It helps prevent the immune system from damaging the brain and spinal cord and may slow the progression of the disease.
Dosage form: capsules, hard, intestinal
Active substance Dosage dimethyl fumarate 240 mg ATC: L04AX07
-
The medicine is used to treat relapsing-remitting multiple sclerosis (MS) in people over 13 years of age. It helps prevent the immune system from damaging the brain and spinal cord and may slow the progression of the disease.
Dosage form: capsules, hard, intestinal
Active substance Dosage dimethyl fumarate 120 mg ATC: L04AX07
-
This medicine is used to treat relapsing forms of multiple sclerosis (MS) in patients aged 13 years and older. It helps prevent the immune system from damaging the brain and spinal cord and may slow the progression of the disease.
Dosage form: capsules, hard, intestinal
Active substance Dosage dimethyl fumarate 240 mg ATC: L04AX07
-
This medicine is used in adults with multiple myeloma (a type of malignant white blood cell cancer). It may be used in combination with other medicines, such as bortezomib and dexamethasone, or with dexamethasone alone, depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 1 mg ATC: L04AX06
-
The medicine is used in adults with multiple myeloma (a type of malignant white blood cell cancer). It may be administered alone with dexamethasone or in combination with other medicines, such as bortezomib.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 2 mg ATC: L04AX06
-
This medicine is used in adults to treat multiple myeloma. It may be administered in combination with two other medicines (bortezomib and dexamethasone) or with only one (dexamethasone), depending on the patient's treatment history.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 3 mg ATC: L04AX06
-
The medicine is used in adults for the treatment of multiple myeloma (a type of malignant tumor that attacks white blood cells). It may be used alone with dexamethasone or in combination with other medicines, such as bortezomib.
Dosage form: capsules, hard
Active substance Dosage pomalidomide 4 mg ATC: L04AX06